newsfilter
← Interviews
a16z22 min

Pande & Conde: When (and How) Biology Becomes Engineering

Pande, Conde, Vijay Pandey

Fireside Chat, Interview

The bioindustry is undergoing a fundamental shift from stochastic discovery to design-driven engineering by treating biological systems as modular, interchangeable components akin to mechanical parts. This paradigm leverages interdisciplinary convergence, mature technologies like CRISPR, and machine learning to transform drug development into a reproducible, iterative process where platform value compounds over time. Consequently, pharmaceutical companies are redefining themselves as data-generating entities that prioritize scalable, predictive systems over single asset creation to achieve complex, long-term health goals.